Search Count: 10
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2016-08-17 Classification: TRANSFERASE/TRANSFERASE inhibitor Ligands: 6YD |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.67 Å Release Date: 2016-08-17 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 6YE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2015-09-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 4S1 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.66 Å Release Date: 2015-09-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 4S2 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2015-09-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 4S3 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2015-05-20 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 4GD |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.64 Å Release Date: 2015-05-20 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 4GF |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.73 Å Release Date: 2015-05-13 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 42P |
 |
The Discovery Of Potent, Selectivity, And Orally Bioavailable Pyrozoloquinolines As Pde10 Inhibitors For The Treatment Of Schizophrenia
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2012-01-25 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 0CV, MG, ZN, PO4 |
 |
Discovery Of Orally Active Pyrazoloquinoline As A Potent Pde10 Inhibitor For The Management Of Schizophrenia
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2011-12-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: C1L, MG, ZN |